Status:
UNKNOWN
Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic
Lead Sponsor:
Hospital St. Joseph, Marseille, France
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study COVID-EP is to classify all the complications occurring after the diagnosis of pulmonary embolism in patients tested initially COVID-19 positive and negative by RT-PCR (on nas...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years,
- Diagnosed for pulmonary embolism between April 1st and April 30th, 2020; (treated by ambulatory care or hospitalized),
- Having given free and informed written consent,
- Being affiliated with or benefiting from a social security scheme.
Exclusion
- Subject to a measure for the protection of justice.
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04465656
Start Date
July 7 2020
End Date
April 30 2021
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint Joseph Marseille
Marseille, France